Is Napping Good for Seniors?
When you are sleepy, a nap seems like a wise idea. However, that midday shut-eye might indicate you are at higher risk of hypertension and stroke, according to new research.
Can My Pet Help Me in Old Age?
We all know that Fido and Fifi can be a balm for your heart. As it turns out, a pet also may help protect your brain.
What Games Keep My Mind Sharp as I Age?
It’s never too late to benefit from taking up this type of activity.
Elderly Woman Thanks Firefighters for Ride to Visit Husband
An 87-year-old woman stranded for hours by a taxi company was given a free ride home in a fire engine, thanks to San Diego firefighters who noticed she was in distress.
How Much Sleep Should Seniors Get?
Sleeping too little or too much is associated with poorer cognitive performance and mental health.
Can Playing Golf Lower Risk of Dementia?
Japanese study found older male golfers were 37% less likely to get dementia.
Research News in Finding a Cure for Alzheimer’s
More than 40 genes have been linked to Alzheimer’s disease for the first time, in a “landmark” study offering hope for better diagnosis and treatment.
Can End-of-Life Planning Increase Control for Cancer Patients?
An end-of-life program that enables patients with advanced cancer to document their wishes can enhance feelings of life completion, improve relationships with healthcare providers and decrease death-related anxiety, according to a presentation at the 2021 Virtual Association of Community Cancer Centers National Oncology Conference.
What Does UK Study Say about Dementia Patients Seeing the Same Doctor?
Study finds patients who consistently see same GP have fewer health complications and emergency hospital visits.
What’s the Latest on Controversial New Alzheimer’s Drug Aduhelm?
Medicare officials have decided that the federal health insurance program should only cover the controversial new Alzheimer’s drug Aduhelm for patients who are participating in approved clinical trials. The preliminary decision, reached after lengthy deliberations, was released on Tuesday by the Center for Medicare and Medicaid Services, or C.M.S. If it is finalized later this year, it would significantly limit the number of patients who could use the expensive drug.
